A citation-based method for searching scientific literature

Tina Costacou, Rhobert W Evans, Trevor J Orchard. J Clin Lipidol 2011
Times Cited: 39







List of co-cited articles
566 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Type 1 diabetes and coronary artery disease.
Trevor J Orchard, Tina Costacou, Adam Kretowski, Richard W Nesto. Diabetes Care 2006
183
30

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Trevor J Orchard, Jon C Olson, John R Erbey, Katherine Williams, Kimberly Y-Z Forrest, Leslie Smithline Kinder, Demetrius Ellis, Dorothy J Becker. Diabetes Care 2003
319
25

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
Sabita S Soedamah-Muthu, Nish Chaturvedi, Monika Toeller, Barry Ferriss, Paolo Reboldi, Georges Michel, Christos Manes, John H Fuller. Diabetes Care 2004
180
23

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
23

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
Sabita S Soedamah-Muthu, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun. Diabetes Care 2006
236
20

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
Georgia Pambianco, Tina Costacou, Demetrius Ellis, Dorothy J Becker, Ronald Klein, Trevor J Orchard. Diabetes 2006
304
17

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
Amit V Khera, Marina Cuchel, Margarita de la Llera-Moya, Amrith Rodrigues, Megan F Burke, Kashif Jafri, Benjamin C French, Julie A Phillips, Megan L Mucksavage, Robert L Wilensky,[...]. N Engl J Med 2011
17

Effects of torcetrapib in patients at high risk for coronary events.
Philip J Barter, Mark Caulfield, Mats Eriksson, Scott M Grundy, John J P Kastelein, Michel Komajda, Jose Lopez-Sendon, Lori Mosca, Jean-Claude Tardif, David D Waters,[...]. N Engl J Med 2007
17

Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes.
Aaron M Secrest, Dorothy J Becker, Sheryl F Kelsey, Ronald E Laporte, Trevor J Orchard. Diabetes 2010
175
17

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.
Shona J Livingstone, Helen C Looker, Eleanor J Hothersall, Sarah H Wild, Robert S Lindsay, John Chalmers, Stephen Cleland, Graham P Leese, John McKnight, Andrew D Morris,[...]. PLoS Med 2012
187
17

HDL cholesterol efflux capacity and incident cardiovascular events.
Anand Rohatgi, Amit Khera, Jarett D Berry, Edward G Givens, Colby R Ayers, Kyle E Wedin, Ian J Neeland, Ivan S Yuhanna, Daniel R Rader, James A de Lemos,[...]. N Engl J Med 2014
820
17

Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.
Rabea Asleh, Julia Guetta, Shiri Kalet-Litman, Rachel Miller-Lotan, Andrew P Levy. Circ Res 2005
157
15

Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.
Melissa Simpson, Janet K Snell-Bergeon, Gregory L Kinney, Orit Lache, Rachel Miller-Lotan, Yefim Anbinder, Marian J Rewers, Andrew P Levy. Cardiovasc Diabetol 2011
35
17

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Uzi Milman, Shany Blum, Chen Shapira, Doron Aronson, Rachel Miller-Lotan, Yefim Anbinder, Junia Alshiek, Lawrence Bennett, Maria Kostenko, Michele Landau,[...]. Arterioscler Thromb Vasc Biol 2008
183
15

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Andrew P Levy, Hertzel C Gerstein, Rachel Miller-Lotan, Robert Ratner, Matthew McQueen, Eva Lonn, Janice Pogue. Diabetes Care 2004
64
15


Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.
Tina Costacou, Robert E Ferrell, Trevor J Orchard. Diabetes 2008
90
15

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
Dana Dabelea, Gregory Kinney, Janet K Snell-Bergeon, John E Hokanson, Robert H Eckel, James Ehrlich, Satish Garg, Richard F Hamman, Marian Rewers. Diabetes 2003
179
15

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
Benjamin F Voight, Gina M Peloso, Marju Orho-Melander, Ruth Frikke-Schmidt, Maja Barbalic, Majken K Jensen, George Hindy, Hilma Hólm, Eric L Ding, Toby Johnson,[...]. Lancet 2012
15



Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.
Rabea Asleh, Rachael Miller-Lotan, Michael Aviram, Tony Hayek, Michael Yulish, Joanne E Levy, Benjamin Miller, Shany Blum, Uzi Milman, Chen Shapira,[...]. Circ Res 2006
64
12

Haptoglobin genotype and renal function decline in type 1 diabetes.
Tina Costacou, Robert E Ferrell, Demetrius Ellis, Trevor J Orchard. Diabetes 2009
40
12

Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
Rabea Asleh, Stuart Marsh, Mark Shilkrut, Ofer Binah, Julia Guetta, Flavio Lejbkowicz, Ben Enav, Naim Shehadeh, Yoram Kanter, Orit Lache,[...]. Circ Res 2003
196
12


The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.
Shany Blum, Moshe Vardi, Nina S Levy, Rachel Miller-Lotan, Andrew P Levy. Atherosclerosis 2010
37
13

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
K Hirano, S Yamashita, N Nakajima, T Arai, T Maruyama, Y Yoshida, M Ishigami, N Sakai, K Kameda-Takemura, Y Matsuzawa. Arterioscler Thromb Vasc Biol 1997
220
12

Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
C E Lloyd, L H Kuller, D Ellis, D J Becker, R R Wing, T J Orchard. Arterioscler Thromb Vasc Biol 1996
124
12

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
William E Boden, Jeffrey L Probstfield, Todd Anderson, Bernard R Chaitman, Patrice Desvignes-Nickens, Kent Koprowicz, Ruth McBride, Koon Teo, William Weintraub. N Engl J Med 2011
12

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
Wim A van der Steeg, Ingar Holme, S Matthijs Boekholdt, Mogens Lytken Larsen, Christina Lindahl, Erik S G Stroes, Matti J Tikkanen, Nicholas J Wareham, Ole Faergeman, Anders G Olsson,[...]. J Am Coll Cardiol 2008
248
12

Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
Janice C Zgibor, Gretchen A Piatt, Kristine Ruppert, Trevor J Orchard, Mark S Roberts. Diabetes Care 2006
54
12

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.
S P Laing, A J Swerdlow, S D Slater, A C Burden, A Morris, N R Waugh, W Gatling, P J Bingley, C C Patterson. Diabetologia 2003
474
12

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus.
A S Krolewski, E J Kosinski, J H Warram, O S Leland, E J Busick, A C Asmal, L I Rand, A R Christlieb, R F Bradley, C R Kahn. Am J Cardiol 1987
523
12

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
Per-Henrik Groop, Merlin C Thomas, John L Moran, Johan Wadèn, Lena M Thorn, Ville-Petteri Mäkinen, Milla Rosengård-Bärlund, Markku Saraheimo, Kustaa Hietala, Outi Heikkilä,[...]. Diabetes 2009
372
12

The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification.
H M Colhoun, M B Rubens, S R Underwood, J H Fuller. J Am Coll Cardiol 2000
105
12

Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
Barbara E K Klein, Ronald Klein, Patrick E McBride, Karen J Cruickshanks, Mari Palta, Michael D Knudtson, Scot E Moss, Jennifer O Reinke. Arch Intern Med 2004
176
12


Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.
M E Larkin, J-Y Backlund, P Cleary, M Bayless, B Schaefer, J Canady, D M Nathan. Diabet Med 2010
26
19

Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis.
Rachel R Huxley, Sanne A E Peters, Gita D Mishra, Mark Woodward. Lancet Diabetes Endocrinol 2015
164
12

Glycemic control and excess mortality in type 1 diabetes.
Marcus Lind, Ann-Marie Svensson, Mikhail Kosiborod, Soffia Gudbjörnsdottir, Aldina Pivodic, Hans Wedel, Sofia Dahlqvist, Mark Clements, Annika Rosengren. N Engl J Med 2014
434
12


Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.
Andrew P Levy, Irit Hochberg, Kathleen Jablonski, Helaine E Resnick, Elisa T Lee, Lyle Best, Barbara V Howard. J Am Coll Cardiol 2002
222
10

Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction.
Mahmoud Suleiman, Doron Aronson, Rabea Asleh, Michael R Kapeliovich, Ariel Roguin, Simcha R Meisel, Michael Shochat, Abeer Sulieman, Shimon A Reisner, Walter Markiewicz,[...]. Diabetes 2005
102
10

Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
Shany Blum, Uzi Milman, Chen Shapira, Rachel Miller-Lotan, Lawrence Bennett, Maria Kostenko, Michele Landau, Shlomo Keidar, Yishai Levy, Alexander Khemlin,[...]. Arterioscler Thromb Vasc Biol 2008
23
17

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Rabea Asleh, Shany Blum, Shiri Kalet-Litman, Jonia Alshiek, Rachel Miller-Lotan, Roy Asaf, Wasseem Rock, Michael Aviram, Uzi Milman, Chen Shapira,[...]. Diabetes 2008
93
10


High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
T Gordon, W P Castelli, M C Hjortland, W B Kannel, T R Dawber. Am J Med 1977
10

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
10


HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
Philip Barter, Antonio M Gotto, John C LaRosa, Jaman Maroni, Michael Szarek, Scott M Grundy, John J P Kastelein, Vera Bittner, Jean-Charles Fruchart. N Engl J Med 2007
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.